News
-
-
-
-
PRESS RELEASE
THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
The NAGA Group AG confirms FY 2025 revenues exceeding expectations with audited EBITDA of EUR 3.7 million and 3.5% FX-adjusted revenue growth, showcasing strong operational transformation and improved profitability -
-
-
REGULATED PRESS RELEASE
Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
bioMérieux submits Dual 510(k)/CLIA Waiver application to FDA for BIOFIRE® SPOTFIRE® Vaginitis Panel, a rapid PCR test for women's health diagnostics at point of care -
-
-
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
